Llwytho...
Evolution of Anticoagulant and Antiplatelet Therapy: Benefits and Risks of Contemporary Pharmacologic Agents and Their Implications for Myonecrosis and Bleeding in Percutaneous Coronary Intervention
Periprocedural myonecrosis, as evidenced by elevated creatine kinase–myocardial bound (CK‐MB) levels, occurs in up to 25% of patients undergoing percutaneous coronary intervention (PCI) and has been linked with an increased risk of adverse short‐ and long‐term clinical outcomes. Such myonecrosis ari...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Cardiol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wiley Periodicals, Inc.
2007
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653096/ https://ncbi.nlm.nih.gov/pubmed/18228647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20237 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|